Gilead Sciences (GILD) Common Equity (2009 - 2026)
Gilead Sciences posted quarterly Common Equity of $23.5 billion for Q1 2026, up 23.26% year-on-year from $19.1 billion in Q1 2025, and up 3.58% on a QoQ basis from $22.7 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of Common Equity data on file, last reported at $23.5 billion in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 23.26% year-over-year to $23.5 billion; the trailing twelve-month figure through Mar 2026 stood at $23.5 billion (up 23.26% YoY), and the FY2025 full-year result was $22.7 billion, up 17.96% from the prior year.
- Common Equity for Q1 2026 stood at $23.5 billion, up from $22.7 billion in the prior quarter.
- Across five years, Common Equity topped out at $23.5 billion in Q1 2026 and bottomed at $17.5 billion in Q1 2024.
- The 5-year median for Common Equity is $20.9 billion (2023), against an average of $20.5 billion.
- The widest annual swing landed in 2024, when Common Equity fell 17.32%; it then rose 23.26% in 2026.
- A 5-year view of Common Equity shows it stood at $21.2 billion in 2022, then climbed by 7.26% to $22.7 billion in 2023, then retreated by 15.4% to $19.2 billion in 2024, then rose by 17.96% to $22.7 billion in 2025, then rose by 3.58% to $23.5 billion in 2026.
- The last three Common Equity figures came in at $23.5 billion (Q1 2026), $22.7 billion (Q4 2025), and $21.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 31.20 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 81.19 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -6.61 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 45.93 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 9.19 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 23.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 90.40 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 20.10 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 21.78 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.52 Bn |
| Dec 31, 2025 | 22.70 Bn |
| Sep 30, 2025 | 21.54 Bn |
| Jun 30, 2025 | 19.59 Bn |
| Mar 31, 2025 | 19.08 Bn |
| Dec 31, 2024 | 19.25 Bn |
| Sep 30, 2024 | 18.39 Bn |
| Jun 30, 2024 | 18.20 Bn |
| Mar 31, 2024 | 17.46 Bn |
| Dec 31, 2023 | 22.75 Bn |
| Sep 30, 2023 | 22.24 Bn |
| Jun 30, 2023 | 21.09 Bn |
| Mar 31, 2023 | 20.94 Bn |
| Dec 31, 2022 | 21.21 Bn |
| Sep 30, 2022 | 21.06 Bn |
| Jun 30, 2022 | 20.22 Bn |
| Mar 31, 2022 | 19.92 Bn |
| Dec 31, 2021 | 21.06 Bn |
| Sep 30, 2021 | 21.47 Bn |
| Jun 30, 2021 | 19.71 Bn |
| Mar 31, 2021 | 18.96 Bn |
| Dec 31, 2020 | 18.22 Bn |
| Sep 30, 2020 | 17.47 Bn |
| Jun 30, 2020 | 18.14 Bn |
| Mar 31, 2020 | 22.18 Bn |
| Dec 31, 2019 | 22.65 Bn |
| Sep 30, 2019 | 20.74 Bn |
| Jun 30, 2019 | 22.75 Bn |
| Mar 31, 2019 | 22.09 Bn |
| Dec 31, 2018 | 21.53 Bn |
| Sep 30, 2018 | 23.01 Bn |
| Jun 30, 2018 | 21.73 Bn |
| Mar 31, 2018 | 20.65 Bn |
| Dec 31, 2017 | 20.50 Bn |
| Sep 30, 2017 | 24.85 Bn |
| Jun 30, 2017 | 23.09 Bn |
| Mar 31, 2017 | 20.92 Bn |
| Dec 31, 2016 | 19.36 Bn |
| Sep 30, 2016 | 16.87 Bn |
| Jun 30, 2016 | 16.12 Bn |
| Mar 31, 2016 | 14.02 Bn |
| Dec 31, 2015 | 19.11 Bn |
| Sep 30, 2015 | 17.94 Bn |
| Jun 30, 2015 | 16.63 Bn |
| Mar 31, 2015 | 17.18 Bn |
| Dec 31, 2014 | 15.82 Bn |
| Sep 30, 2014 | 13.86 Bn |
| Jun 30, 2014 | 16.43 Bn |
| Mar 31, 2014 | 13.39 Bn |
| Dec 31, 2013 | 11.75 Bn |
| Sep 30, 2013 | 11.19 Bn |
| Jun 30, 2013 | 11.09 Bn |
| Mar 31, 2013 | 10.39 Bn |
| Dec 31, 2012 | 9.54 Bn |
| Sep 30, 2012 | 8.60 Bn |
| Jun 30, 2012 | 8.08 Bn |
| Mar 31, 2012 | 7.31 Bn |
| Dec 31, 2011 | 6.87 Bn |
| Sep 30, 2011 | 6.12 Bn |
| Jun 30, 2011 | 6.21 Bn |
| Mar 31, 2011 | 6.18 Bn |
| Dec 31, 2010 | 6.12 Bn |
| Sep 30, 2010 | 5.88 Bn |
| Mar 31, 2010 | 7.50 Bn |
| Dec 31, 2009 | 6.51 Bn |
| Sep 30, 2009 | 5.65 Bn |
| Jun 30, 2009 | 5.31 Bn |